Tulane Institute-Sports Med is categorized under Sports Medicines in New Orleans, LA .
Tulane Institute-Sports Med was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Beaua Boraks, Office Manager at the company’s single location by writing to 202 Mcalister Extension, New Orleans, Louisiana LA 70118 or by phoning (504) 864-1476. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tulane Institute-Sports Med |
| Contact Person: | Beaua Boraks, Office Manager |
| Address: | 202 Mcalister Extension, New Orleans, Louisiana 70118 |
| Phone Number: | (504) 864-1476 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Sports Medicines |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Tulane Institute-Sports Med was started in 0 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Beaua Boraks, Office Manager for inquiries that concern Tulane Institute-Sports Med by calling the company number (504) 864-1476, as your correspondence is most welcome. Additionally, the physical location of the single location of Tulane Institute-Sports Med can be found at the coordinates 29.94296,-90.11638 as well as the street address 202 Mcalister Extension in New Orleans, Louisiana 70118.
For its online presence, you may visit Tulane Institute-Sports Med’s website at and engage with its social media outlets through on Twitter and on Facebook.